This study investigates the effect of exenatide, a FDA approved medication for the treatment
of type 2 diabetes on sleep duration and quality. Individuals with type 2 diabetes will be
studied before and during treatment with Exenatide.
Enrolled individuals will be asked to come to the University of Chicago for 3-4 outpatient
visits over the course of 3-4 months.